Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.

about

Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.

Item

http://www.wikidata.org/entity/Q55313306

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Evaluation of different infant ...... a randomised controlled trial.

@en

Evaluation of different infant ...... ating pneumococcal vaccination

@nl

type

Item

label

Evaluation of different infant ...... a randomised controlled trial.

@en

Evaluation of different infant ...... ating pneumococcal vaccination

@nl

prefLabel

Evaluation of different infant ...... a randomised controlled trial.

@en

Evaluation of different infant ...... ating pneumococcal vaccination

@nl

P1476

Evaluation of different infant ...... a randomised controlled trial.

@en

P2093

Anne Balloch

http://www.w3.org/2001/XMLSchema#string

Beth Temple

http://www.w3.org/2001/XMLSchema#string

Cattram Duong Nguyen

http://www.w3.org/2001/XMLSchema#string

Doan Y Uyen

http://www.w3.org/2001/XMLSchema#string

Edward Kim Mulholland

http://www.w3.org/2001/XMLSchema#string

Heidi Smith-Vaughan

http://www.w3.org/2001/XMLSchema#string

Kathryn Bright

http://www.w3.org/2001/XMLSchema#string

Nguyen Thi Minh Phuong

http://www.w3.org/2001/XMLSchema#string

Nguyen Trong Toan

http://www.w3.org/2001/XMLSchema#string

Paul Licciardi

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

Measuring nasal bacterial load and its association with otitis media.

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

Serotype replacement in disease after pneumococcal vaccination

Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray.

The potential indirect effect of conjugate pneumococcal vaccines.

Epidemiological differences among pneumococcal serotypes.

Nasopharyngeal colonization: a target for pneumococcal vaccination.

P304

e019795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2017-019795

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Satzke

P577

2018-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29884695

http://www.w3.org/2001/XMLSchema#string

P921

Vietnam

P932

6009474

http://www.w3.org/2001/XMLSchema#string